4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-061067
Chief Legal Officer gave up 497 shares (to pay taxes)
- Chief Legal Officer acquired 1,733 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2019-12-16 | Option exercise | +1,733 | 83,945 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2019-12-16 | Shares withheld for taxes | −497 | $1.80 | $895 | 83,448 | D |
| Derivatives | |||||||
| Ali-Jackson Kamil Chief Legal Officer | 2019-12-16 | Option exercise · Restricted Stock Units | −1,733 | 1,734 | D | ||
Loading xslF345X03/doc4.xml…